Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Follow us on Google+Follow us on TwitterFind us on LinkedInFind Us on FacebookSubscribe to our RSS FeedsSubscribe to our YouTube ChannelFind us on RebelMouse

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for December 20, 2013 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



Reed Group Releases Beta Formulary for ACOEM Practice Guidelines

New interactive formulary relates ACOEM evidence-based recommendations to NDC data from the FDA
 
x-small text small text medium text large text

    WESTMINSTER, CO, December 20, 2013 /24-7PressRelease/ -- Reed Group, the recognized leader in managing employee absence and the exclusive publisher and distributor of ACOEM's Practice Guidelines, today launched a major new feature of the ACOEM Practice Guidelines, a formulary linking various data elements to the Guidelines' medication and injection recommendations.

The formulary is in a beta release to allow qualified users to provide feedback and help direct improvements to the formulary.

"The formulary is a major leap forward. It helps both providers and payers rapidly determine whether a medication is appropriate for the specific stage of a patient's disorder," said Dr. Kurt Hegmann, ACOEM Guidelines Editor in Chief. "Clinicians and professionals have a Hippocratic responsibility to use evidence-based guidelines to help make sound decisions regarding treatments or durations. Using evidence-based guidelines ensures faster healing, quicker return to work and fosters return-to-work decisions that are made on solid science and should be the first choice for anyone seeking the best outcomes."

"This formulary directly links the scientific evidence behind the use of specific medications for specific conditions and provides information on alternative drugs which may be useful or, conversely, are potentially harmful. It is one of the clinically useful formularies currently available which also provides the necessary information for claims adjustors, said Dr. Kathryn Mueller, medical director of the Colorado Division of Workers Compensation.

Clinicians, utilization reviewers, insurance adjusters and others with a professional need for the tool who would like free access to APGI, and who are willing to provide feedback by completing a short survey can email guidelines@reedgroup.com to request a free trial subscription to the ACOEM Practice Guidelines and the beta formulary.

About Reed Group
Reed Group, Ltd., a wholly owned subsidiary of the Guardian Life Insurance Company of America, is the recognized leader in helping organizations reduce the cost, compliance risk and complexity of employee absence. Our products and services address FMLA, ADA, state and other leave laws, workers' compensation, and short- and long-term disability programs. Headquartered in Westminster, Colorado, Reed Group has been a trusted partner to employers, insurers, TPAs, government organizations, attorneys, and health care providers for over 35 years. Reed Group's world-class team of clinical and absence management experts help organizations deploy Reed Group products and services to improve employee health and productivity. For more information, visit http://www.reedgroup.com.

About ACOEM
The American College of Occupational and Environmental Medicine (ACOEM) represents more than 4,000 physicians specializing in occupational and environmental medicine. Founded in 1916, ACOEM is the nation's largest medical society dedicated to promoting the health of workers through preventive medicine, clinical care, disability management, research, and education. For more information, visit http://www.acoem.org.



---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Contact Information:
Rachel Berry
Reed Group

Westminster, Colorado
United States
Voice: 303 407 0674
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.